| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |